Anne Schmidt is healthcare specialist in GS1 Denmark. She has a background as a nurse, and a master in health science.
Since 2015 she has worked for GS1 Denmark, where the main focus is helping the members implementing GS1 standards to increase patient safety and ensure efficiency.
Maria Hedwall currently hold the position as Sr Director Project Management in the Global Portfolio and Project management organization at AstraZeneca R&D. She is accountable for the early cardiovascular and respiratory pipeline delivery and her organization manages a variety of modalities of drug projects in the pre-clinical phase up to PH3ID. Maria brings an understanding of drug development based on 19 years of experience in the clinical, outsourcing and innovative medicines functions with a special interest in collaboration and efficient drug project planning and execution.
As a person she has an ambitious mindset and is driven of the capability to turn strategy into delivery and action. As the goal oriented person she is, she want to push boundaries and make difference preferably by generating creative & innovative solutions.
Rasmus Hogreffe, MSc.Med., MBA is considered as a Virtual Clinical Trials expert. His main goal is to improve treatment for patients by making trials better and faster than ever before, using digital and remote innovations.
Rasmus has extensive experience in the pharmaceutical industry and has been involved in more than 60 clinical trials, giving him a broad knowledge regarding every aspect of clinical research.
Furthermore, Rasmus is a serial entrepreneur and has a successful record of starting and selling companies within his broad scope of interests: Digitalization of clinical trials, Patient recruitment, Real World Data, and Health innovation.
In addition, as an external lecturer and supervisor at Aalborg University, Rasmus has developed and given courses and workshops on management of clinical studies on topics such as the development of recruitment and retention strategies, site-optimization, site-selection and patient engagement to sponsors, investigators and study teams at leading medical centers.
His innovative approach within the field of digital health, Patient Recruitment, and Virtual Clinical Trials make him a frequently used chairman and speaker.
…………….
Specialties: Patient #Recruitment, Patient #engagement, #Study start-up, Site #optimization Project #Management, #Medical #Market #Access, Business #Development, #Marketing, Health Economy, Economy analysis, #HEOR
Dr. Willie McKinney is an established regulatory and inhalation toxicology expert with over two decades of research, product development, and regulatory strategy experience in the Consumer-Packaged Goods industry. As the founder and CEO of McKinney Regulatory Science Advisors, LLC, he leverages his extensive background, including his previous role on the FDA’s Tobacco Product Scientific Advisory Committee and his past position as Vice President of Regulatory Sciences at Altria, to guide clients through multiple constantly evolving regulatory landscapes.
Dr. McKinney’s knowledge and experience are widely respected. He holds a Ph.D. in Environmental Toxicology from the University of North Carolina School of Public Health and is certified by the American Board of Toxicology. He launched McKinney Specialty Labs, LLC in January 2024 to offer specialized aerosol testing services as well as chemical and GLP toxicology analysis.
Together, McKinney Regulatory Science Advisors, LLC, and the newly established lab provide over 25 years of combined expertise in regulatory strategy, application filing, and product testing. This suite of services is customized to meet the unique needs of each client, guaranteeing integrity and quality at every step. Dr. McKinney’s leadership remains instrumental in driving scientific research and regulatory compliance forward.
